Akt Activation is Required for TGF-β1-Induced Osteoblast Differentiation of MC3T3-E1 Pre-Osteoblasts

Abstract

BackgroundWe have previously reported that repeated treatment of human periodontal ligament cells and murine pre-osteoblast MC3T3-E1 cells with transforming growth factor-beta 1 (TGF-β1) inhibited their osteoblastic differentiation because of decreased insulin-like growth factor-1 (IGF-1) secretion. We also found that IGF-1/PI3K signaling plays an important role in osteoblast differentiation induced by TGF-β1 treatment; however, the downstream signaling controlling this remains unknown. The aim of this current study is to investigate whether Akt activation is required for osteoblast differentiation.Methodology/Principal FindingsMC3T3-E1 cells were cultured in osteoblast differentiation medium (OBM) with or without 0.1 ng/mL TGF-β1. OBM containing TGF-β1 was changed every 12 h to provide repeated TGF-β1 administration. MC3T3-E1 cells were infected with retroviral vectors expressing constitutively active (CA) or dominant-negative (DN)-Akt. Alkaline phosphatase (ALP) activity and osteoblastic marker mRNA levels were substantially decreased by repeated TGF-β1 treatment compared with a single TGF-β1 treatment. However, expression of CA-Akt restored ALP activity following TGF-β1 treatment. Surprisingly, ALP activity increased following multiple TGF-β1 treatments as the number of administrations of TGF-β1 increased. Activation of Akt significantly enhanced expression of osteocalcin, but TGF-β1 treatment inhibited this. Mineralization of MC3T3-E1 cells was markedly enhanced by CA-Akt expression under all medium conditions. Exogenous IGF-1 restored the down-regulation of osteoblast-related gene expression by repeated TGF-β1 administration. However, in cells expressing DN-Akt, these levels remained inhibited regardless of IGF-1 treatment. These findings indicate that Akt activation is required for the early phase of osteoblast differentiation of MC3T3-E1 cells induced by TGF-β1. However, Akt activation is insufficient to reverse the inhibitory effects of TGF-β1 in the late stages of osteoblast differentiation.ConclusionsTGF-β1 could be an inducer or an inhibitor of osteoblastic differentiation of MC3T3-E1 cells depending on the state of Akt phosphorylation. Our results indicate that Akt is the molecular switch for TGF-β1-induced osteoblastic differentiation of MC3T3-E1 cells.

Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675

“…TGF‐β seems to stimulate proliferation and early differentiation of OB, but inhibits its terminal differentiation . The precise response may depend on the extracellular milieu, cell density, and the differentiation stage of the cells . In this study, we found that TGF‐β1 remained at a low level after OB induction, and exogenous TGF‐β1 treatment inhibited osteogenic differentiation, consistent with previous studies showing that TGF‐β inhibits the expression of ALP and OCN .…”

Locally Produced BDNF Promotes Sclerotic Change in Alveolar Bone after Nerve Injury

“…TrkB is known to be recruited to the cell surface from the cytoplasm by extracellular BDNF stimulation [9], and in our in vitro experiment, BDNF enhanced trkB expression on the cell surface and promoted the Akt signaling cascade in MC3T3-E1 cells. Regarding the relationship between Akt signaling and osteoblast differentiation, the PI3K/Akt signaling pathway is known to regulate osteoblast differentiation [29–32]. Therefore, it is speculated that the promotion of osteoblast differentiation by exogenous BDNF occurs through trkB receptor by activating the Akt signaling cascade.…”

Extracorporeal Shock Wave Therapy for the Treatment of Osteoarthritis: A Systematic Review and Meta-Analysis

“…ESWT was also found connected with osteogenic transcription factors including VEGF-A and hypoxia inducible factor-1α (HIF-1α), affecting growth of osteoblasts [67]. Meanwhile, ESWT might elevate levels of nitric oxide (NO), bone morphogenetic protein-2 (BMP-2), protein kinase B (PKB), and transforming growth factor-beta 1 (TGF-β1), which facilitate differentiation and proliferation of osteoblasts [68][69][70][71]. Also, it was suggested that ESWT could enhance the expression of Pdia-3, a key point of 1α,25-dihydroxyvitamin D3 (1α,25(OH) 2 D 3 ) signaling pathway [72].…”